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Detection	of	Separase	activity	using	a	cleavage	sensor	in	live	mouse	
oocytes.	
	
Running	head:	Biosensor	for	Separase	activity	in	mouse	oocytes			
Abstract:		Separase	proteolytically	removes	Cohesin	complexes	from	sister	chromatid	arms,	which	is	essential	for	chromosome	segregation.	Regulation	of	Separase	activity	is	essential	for	proper	cell	cycle	progression	and	correct	chromosome	segregation.	Onset	of	Separase	activity	has	not	yet	been	observed	in	live	oocytes.		We	describe	here	a	method	for	detecting	Separase	activity	in	mouse	oocytes	
in	vivo.	This	method	utilizes	a	previously	described	cleavage	sensor	made	up	of	H2B-mCherry	fused	with	Scc1(107-268	aa)-YFP.	The	cleavage	sensor	is	loaded	on	the	chromosomes	through	its	H2B	tag,	and	the	signal	from	both	mCherry	and	YFP	is	 visible.	 Upon	 Separase	 activation	 the	 Scc1	 fragment	 is	 cleaved	 and	 YFP	dissociates	from	the	chromosomes.	The	change	in	the	ratio	between	mCherry	and	YFP	fluorescence	intensity	is	a	readout	of	Separase	activity.			
Keywords:		Separase,	Cohesin,	cleavage	sensor,	oocyte,	chromosome	segregation,	anaphase,	female	meiosis,	Scc1,	live	imaging,	time	lapse.				
1.	Introduction		During	 meiosis	 I,	 chromosomes	 are	 organised	 as	 bivalents,	 where	homologous	chromosomes	are	held	together	via	chiasmata	and	sister	chromatids	are	locked	together	by	a	ring	complex	named	Cohesin	(1,	2).	At	the	metaphase	to	anaphase	 I	 transition,	 Separase	 proteolytically	 cleaves	 Cohesin	 at	 the	chromosome	arms	allowing	chiasmata	resolution	and	chromosome	segregation.	In	 meiosis	 II,	 sister	 chromatids	 are	 held	 together	 by	 the	 remaining	 Cohesin	localized	 at	 the	 centromeres	 (3).	 During	 the	 second	meiotic	 division,	 Separase	cleaves	centromeric	Cohesin	leading	to	sister	chromatid	segregation.	Regulation	of	Separase	activity	is	essential	for	proper	meiotic	chromosome	segregation	 (3,	 4).	 Upon	 translation,	 Separase	 is	 folded	 with	 the	 help	 of	 its	chaperon	and	 inhibitor	Securin	(5).	Separase	remains	 in	a	stable	complex	with	Securin,	 until	 Securin	 is	 targeted	 for	 degradation	 through	 APC	 (Anaphase	Promoting	 Complex)	 dependent	 ubiquitination	 (6–8).	 Separase	 is	 additionally	kept	inactive	by	inhibitory	phosphorylation	mediated	by	Cyclin	B1-Cdk1	kinase	
(9,	10).	Cyclin	B1	is	ubiquitinated	in	an	APC	dependent	manner	at	the	same	time	as	Securin	(11,	12).	Dephosphorylation	of	Separase	and	degradation	of	Securin	result	 in	 activation	 of	 Separase	 (10).	 Separase	 then	 cleaves	 its	 substrates,	 the	kleisin	subunits	of	Cohesin	(Scc1	in	mitosis	or	Rec8	in	meiosis)	(13).		Observing	 and	 measuring	 Separase	 activity	 during	 meiosis	 in	 mouse	oocytes	presents	a	challenge.	Since	Cohesin	complexes	containing	Rec8	are	loaded	during	embryonic	development	in	low	quantities	with	no	turnover	(14,	15),	it	is	
impossible	 to	 introduce	 exogenously	 expressed	 fluorescently	 tagged	 Cohesin	subunits	to	follow	their	cleavage	without	creating	a	transgenic	mouse.	In	addition,	introducing	 fluorescent	 tags	may	 inhibit	the	subunit’s	ability	 to	 integrate	 into	a	complex.	A	different	approach	for	 the	detection	of	Separase	activity	 in	vivo	has	been	developed	in	mitotic	cells	(16),	which	we	have	adapted	in	oocyte	meiosis.	We	describe	a	method	of	detecting	Separase	activity	in	mouse	oocytes	in	
vivo.	This	method	utilizes	a	cleavage	sensor,	which	is	a	protein	construct	made	up	of	H2B-mCherry	fused	with	Scc1(107-268	aa)-YFP.	The	H2B	tag	serves	to	bind	the	sensor	 to	 the	 chromosomes,	 the	 Scc1	 fragment	 is	 a	 very	 efficient	 Separase	substrate,	 and	 the	 ratio	 of	 YFP	 and	 mCherry	 fluorescence	 levels	 on	 the	chromosomes	allows	the	detection	of	the	cleavage	event.		mRNA	 of	 the	 cleavage	 sensor	 is	 injected	 in	 mature	 prophase	 arrested	oocytes	and	cleavage	sensor	protein	expression	begins.	After	allowing	sufficient	time	for	expression,	the	prophase	arrest	is	lifted,	chromosomes	condense	and	the	cleavage	 sensor	 binds	 to	 the	 chromosomes.	 Its	 fluorescence	 can	 be	 followed	through	live	imaging.	When	 Separase	 is	 activated	 at	 the	metaphase-to-anaphase	 transition	 of	meiosis	I,	it	cleaves	Scc1-YFP	with	high	efficiency	leading	to	YFP	dissociation	from	the	 chromosomes,	 visible	 as	 a	 sharp	 decrease	 of	 YFP	 compared	 to	 mCherry	fluorescence.	This	can	be	clearly	observed	by	live	imaging	of	oocytes	(Fig.	1).		The	 cleavage	 sensor	 is	 not	 included	 into	 the	 endogenous	 Cohesin	complexes	and	its	expression	does	not	impede	cleavage	of	the	endogenous	Rec8	and	 chromosome	 separation.	 This	 sensor	 may	 be	 used	 in	 different	 genetic	backgrounds.	Moreover,	variants	of	this	sensor	can	be	created	depending	on	the	aim	of	the	experiments.	It	allows	the	observation	of	Separase	activity	through	time	lapse	imaging,	detection	of	activation	and	inactivation	of	Separase	activity	as	well	as	 its	 efficiency	 in	 different	 conditions.	 The	 cleavage	 sensor	 is	 a	 powerful	 and	elegant	 tool	 useful	 for	 observation	 and	measuring	 Separase	 activity	 in	 mouse	oocytes	in	vivo.	In	this	chapter	we	describe	collection	of	mature	prophase	arrested	mouse	oocytes,	 microinjection	 of	 the	 cleavage	 sensor	 mRNA,	 time	 lapse	 imaging	 of	oocytes	 during	 metaphase-to-anaphase	 I	 transition	 and	 observation	 and	measurement	of	Separase	activity.				
2.	Materials		
2.1.	Collection	of	oocytes		 1. 9-14	week-old	mice,	strain	CD1	Swiss	(Janvier	labs,	France).	2. Sterile-filtered,	 suitable	 for	mouse	 embryo	 culture	M2	medium	 (Sigma)	supplemented	 with	 penicillin	 (final	 concentration	 1.678	 mM)	 and	streptomycin	 (final	 concentration	 0.689	 mM),	 and	 where	 indicated	supplemented	with	100	mg/ml	dbcAMP	(dibutyryl	cyclic	AMP).	3. Mineral	oil	suitable	for	mouse	embryo	cell	culture	(Sigma).	4. 60	mm	easy	grip	polystyrene	tissue	culture	dishes	(Falcon).	5. Mouth	pipette:	plastic	tubing	connected	to	a	mouthpiece.	Attach	the	drawn	out	glass	Pasteur	pipette	to	the	tubing	and	use	it	for	collection	and	cleaning	of	oocytes.	
6. 25G	16mm	BD	Microlance	hypodermic	needle	mounted	on	a	1ml	syringe.	7. Dissection	scissors	and	forceps.	8. Incubator	set	to	38°C.	9. Binocular	dissection	microscope	combined	with	a	heating	plate.		
2.2.	Microinjection	of	oocytes		 1. Glass	capillaries:	outer	diameter	1mm,	inner	diameter	0.75	mm,	length	100	mm	(Harvard	apparatus).	2. Magnetic	puller,	for	example	Narishige	PN-30.	3. Microinjection	microscope,	we	use	a	Nikon	Eclipse	Ti	with	Eppendorf	TransferMan	NK2	micromanipulators	and	TOKAI	HIT	Thermoplate.	4. Eppendorf	FemtoJet	Microinjector	connected	to	the	microinjection	needle	holder.	5. Eppendorf	CellTram	Oil	(or	similar)	manual	microinjector	connected	to	the	holding	pipette	holder.	6. Depression	glass	slide.	7. Holding	 pipette:	 VacuTip	microcapillaries,	 inner	 diameter	 15	 μm,	 outer	diameter	100	μm,	angle	35°.	8. Microloader	tips	20	μl	(Eppendorf).	9. Linearized	and	purified	plasmid	encoding	for	the	cleavage	sensor	under	T7,	T3	or	SP6	promoter	and	allowing	synthesis	of	a	poly(A)-tail	(Note	1).	10. T7/T3/SP6	mMessage	mMachine	transcription	kit	(Invitrogen).	11. Microcentrifuge.	12. RNase-free	water.			
2.3.	Set-up	for	imaging		 1. We	use	an	 inverted	microscope	Zeiss	Axiovert	200M,	 combined	with	an	MS-2000	 automated	 stage	 (Applied	 Scientific	 Instrumentation),	 a	Yokogawa	CSU-X1	 spinning	 disc	 and	 a	 nanopositioner	MCL	Nano-Drive.	The	spinning	disc	unit	is	supplemented	with	a	Quad-Band	Dichroic	filter	13x15x0.5	DI-T405/488/568/647	for	CSU	X1.	The	light	sources	are	50mW	488nm	and	561nm	lasers	(Roper	Scientific).	The	images	are	taken	with	an	EMCCD	camera,	pixel	size	16	x	16	μm	(Photometrics).	2. Objective:	Plan-APOCHROMAT	40x/1.4	Oil	DIC	(UV)	VIS-IR	(Zeiss).	3. The	microscope	is	operated	with	MetaMorph	software.	4. The	body	of	the	microscope	is	encased	in	an	incubation	chamber	heated	by	a	heating	unit	(PeCon).		5. Heating	 insert:	 incubator	 cover,	 incubator	 main	 body,	 lens	 warmer,	operated	by	a	touch	screen	3-channel	temperature	controller	(Chamlide).	6. Imaging	 chamber:	 Chamlide	 CMB	 35mm	 1-well	 magnetic	 chamber	 for	round	coverslips.	7. Round	cover	glasses,	diameter	25mm.	8. Immersion	oil	with	refractive	index	of	1.518.	For	example,	Cargille	Type	37	immersion	oil.			
3.	Methods	
3.1.	Collection	of	oocytes		1.	Prepare	a	60mm	polystyrene	dish	with	6-7	evenly	spaced	drops	of	around	50	μl	pre-warmed	 M2	 medium	 supplemented	 with	 100	 mg/ml	 dbcAMP.	 Cover	 the	drops	entirely	with	mineral	oil.	Store	this	dish	in	a	38°C	heated	environment	(an	incubator	or	a	heated	surface).		2.	Place	another	60mm	polystyrene	dish	on	a	38°C	heated	 stage	of	 a	binocular	microscope	and	put	a	500	μl	drop	of	pre-warmed	38°C	M2	medium	supplemented	with	dbcAMP	in	the	center.	Do	not	cover	it	with	mineral	oil.	3.	 Sacrifice	 a	 non-primed	 8-12	 week	 old	 OF1	 mouse	 (Note	 2)	 by	 cervical	dislocation.	Open	the	peritoneal	cavity	with	a	pair	of	scissors	and	remove	both	ovaries.	4.	Transfer	the	ovaries	into	the	prepared	500	μl	drop	of	M2	medium	supplemented	with	dbcAMP.	From	this	step	on,	all	procedures	should	take	place	on	a	38°C	heated	surface.	5.	Release	the	mature	GV	oocytes	from	the	ovaries	by	piercing	the	follicles	with	a	syringe-mounted	 needle.	During	 this	 procedure,	 the	 ovaries	 can	 be	 held	 down	with	another	needle,	or	a	pair	of	forceps.	6.	 Carefully	 collect	 the	 biggest	 (mature/competent)	 oocytes.	 Transfer	 of	 the	oocytes	is	done	by	mouth-assisted	aspiration	with	a	glass	pipette	(Note	3).		7.	Transfer	all	collected	oocytes	into	a	drop	in	the	prepared	multi-drop	dish.	Some	oocytes	have	 clusters	of	 small	 follicle	 cells	stuck	 to	 them.	Separate	 the	oocytes	from	the	follicle	cells	by	a	series	of	aspirations	into	a	glass	pipette	with	a	diameter	of	the	opening	similar	in	size	to	the	diameter	of	the	oocyte.	Cleaning	the	oocytes	can	be	performed	in	other	drops	of	M2	medium	in	the	same	dish.	8.	Take	only	the	mature	GV	oocytes	and	transfer	them	into	an	unused	drop	of	M2	medium.	Mature	GV	oocytes	are	the	largest,	with	a	smooth	thick	zona	pellucida	and	with	a	germinal	vesicle	in	the	center	of	the	oocyte.				
3.2.	Microinjection	of	oocytes		1.	 Prepare	 mRNA	 coding	 for	 the	 cleavage	 sensor	 for	 microinjection	 using	 a	mMessage	mMachine	transcription	kit	well	ahead	and	freeze	down	small	aliquots	for	single	use.	Spin	the	mRNA	solution	for	at	least	30	min	at	13	000	rpm	at	4°C	prior	to	microinjection.	Keep	the	mRNA	solution	on	ice	at	all	times.	2.	Prepare	an	injection	needle	from	a	glass	capillary	using	a	magnetic	puller	(Note	4).	Avoid	touching	both	ends	of	the	capillary	or	the	resulting	needle.	3.	Set	up	a	microinjection	microscope:	turn	on	the	microinjector,	the	thermoplate	and	the	light	source.	Set	up	the	microinjector	to	Function	0	(Change	capillary).		4.	Fill	the	microinjection	needle	with	1	-	1.6	μl	of	mRNA	solution	(Note	5).	Attach	the	microinjection	needle	to	the	needle	holder.	Attach	the	holding	pipette	to	the	holding	pipette	holder.	5.	Form	a	drop	of	3-5	μl	of	pre-warmed	M2	medium	supplemented	with	dbcAMP	on	a	depression	glass	slide	and	cover	it	with	a	small	amount	of	mineral	oil	(about	200	μl).	6.	Transfer	the	oocytes	into	the	drop	on	the	prepared	depression	glass	slide.	Keep	the	oocytes	grouped	together.	
7.	Put	 the	glass	slide	with	the	oocytes	on	the	thermoplate	of	 the	microinjection	microscope,	lower	the	holding	pipette	and	the	microinjection	needle	into	the	drop	so	 that	 their	 tips	appear	at	 the	 same	 level	 as	 the	oocytes	 (Note	6).	Change	 the	microinjection	pump	setting	to	Function	4	(Continuous	flow)	and	press	“Inject”	(Note	7).	8.	Bring	the	tip	of	the	holding	pipette	close	to	an	un-injected	oocyte	and	apply	light	suction	with	the	holding	pipette	pump.	The	suction	force	should	be	strong	enough	to	attach	the	oocyte	to	the	holding	pipette,	but	light	enough	so	that	the	oocyte	does	not	change	shape	or	enter	into	the	holding	pipette.	9.	Bring	 the	 tip	of	 the	microinjection	needle	 close	 to	 the	oocyte	and	adjust	 the	positions	of	the	holding	pipette	and	the	microinjection	needle	(Note	8).		10.	Keeping	the	holding	pipette	steady	bring	the	tip	of	the	microinjection	needle	into	the	oocyte	until	you	see	a	burst-like	change	in	the	oocyte	cytoplasm	(Note	9).	Avoid	piercing	the	nucleus.	11.	Quickly	withdraw	the	needle	at	the	same	angle	(Note	10).	12.	Move	the	holding	pipette	with	the	injected	oocyte	aside	and	release	the	suction	force	(apply	negative	force)	in	the	holding	pipette	pump.	Keep	injected	oocytes	in	a	separate	group	from	un-injected	oocytes.	13.	Repeat	steps	8-12	until	all	oocytes	have	been	injected.	14.	Set	the	microinjector	back	to	function	0.	Lift	the	microinjection	needle	and	the	holding	pipette	from	the	drop.	Transfer	the	glass	slide	with	the	injected	oocytes	on	a	heated	stage	of	a	binocular	microscope.	Transfer	the	oocytes	to	a	clean	drop	of	M2	medium	supplemented	with	dbcAMP.	Separate	and	remove	dead	oocytes	(Note	11).	15.	Incubate	the	injected	oocytes	at	38°C	from	20	min	to	4h	(Note	12).	16.	 To	 release	 oocytes	 from	 the	 GV	 block,	 prepare	 a	 60mm	 polystyrene	 dish	containing	6-7	evenly	spaced	drops	of	M2	medium	(without	dbcAMP).	Cover	the	drops	with	mineral	oil.	Prepare	another	60mm	polystyrene	dish	containing	4-5	drops	 of	 M2	 medium	 (without	 dbcAMP)	 and	 place	 on	 the	 heated	 stage	 of	 a	binocular	microscope.	Do	not	cover	with	mineral	oil.	17.	Transfer	oocytes	consecutively	through	4	or	5	drops	(on	the	dish	without	the	oil),	each	time	mixing	the	oocytes	in	the	medium	and	then	allowing	them	to	settle.	Change	the	medium	in	the	pipette	completely	each	time.	Transfer	all	the	oocytes	into	a	clean	drop	of	M2	medium	in	the	prepared	dish,	covered	with	mineral	oil.	Incubate	from	45min	to	an	hour	at	38°C.	18.	Check	 for	 the	germinal	vesicle	breakdown	 (GVBD)	event	 -	a	sign	of	meiotic	resumption	 and	 entry	 into	 prometaphase	 I.	 When	 this	 happens,	 the	 germinal	vesicle	 in	 the	oocyte	disappears.	Collect	 these	oocytes	and	 transfer	 them	 to	an	unused	drop	of	M2	medium	in	the	same	dish.	If	not	all	oocytes	had	gone	through	GVBD,	check	again	in	10-15	minutes	(Note	13).	19.	Incubate	for	4-6	hours	at	38°C	(Note	14).	GVBD	event	serves	as	a	reference	point	 to	 all	 subsequent	 events	 in	 the	 first	meiotic	 division.	 Anaphase	 I	 usually	takes	place	between	7	and	9	hours	after	GVBD,	depending	on	the	mouse	strain	and	culture	conditions.	OF1	mouse	oocytes	undergo	metaphase-anaphase	I	transition	at	GVBD+7-8h.			
3.3.	Setting	up	for	imaging		
1.	At	least	one	hour	before	starting	the	imaging,	pre-warm	the	imaging	platform.	This	includes	switching	on	a	heating	chamber	or	a	heating	plate	and	an	objective	warmer	in	case	of	an	immersion	objective	(Note	15).	Right	before	the	imaging	turn	on	the	whole	microscope	system.	3.	Assemble	the	imaging	chamber	with	a	clean	cover	glass.	Place	on	a	38°C	heated	surface	or	incubate	in	the	38°C	incubator	until	warm.	3.	Form	small	2	μl	M2	medium	(without	dbcAMP)	drops	in	the	center	of	the	cover	glass	 in	 the	 imaging	chamber	and	cover	with	mineral	oil.	The	number	of	drops	depends	on	the	number	of	the	oocytes	and	the	number	of	experimental	conditions	(Note	16).	4.	Transfer	the	injected	oocytes	into	the	drops	in	the	imaging	chamber,	up	to	15	per	drop,	evenly	spaced.	5.	Apply	pre-heated	immersion	oil	without	air	bubbles	on	the	objective,	place	the	imaging	chamber	with	the	oocytes	on	the	heating	plate	above	the	objective.	Adjust	the	position	of	the	objective	so	that	the	immersion	oil	is	in	contact	with	the	bottom	of	the	imaging	chamber.	
	
	
3.4.	Time-lapse	imaging	
	1.	Using	MetaMorph	interface,	set	up	the	acquisitions	as	follows:	2.	Create	a	folder	where	the	files	from	the	specific	time	lapse	experiment	will	be	stored.	3.	Find	and	save	the	positions	of	all	the	oocytes	in	the	imaging	chamber.		4.	Use	these	channels:	491nm	for	YFP	and	561nm	for	RFP	fluorescence.	Adjust	the	laser	power	and	the	exposition	time	of	491nm	and	561nm	channels	to	as	low	as	possible	(Note	17).	5.	Set	time	lapse:	acquisitions	10-20	min	for	8-10	hours	depending	on	when	the	first	metaphase-anaphase	transition	is	expected.		6.	Z	stacks:	11	slices	with	a	3	μm	interval.	Adjust	the	position	of	the	saved	point	so	that	Z	stacks	would	cover	the	whole	volume	of	the	chromosome	mass.	7.	Start	the	acquisition	(see	Note	18).		
	
3.5.	Quantification	and	analysis	with	ImageJ			1.	Transfer	the	files	to	the	analysis	station.	Using	ImageJ	assemble	raw	images	into	Z-projection	stacks	by	individual	oocyte	and	wavelength.	You	can	do	this	manually	or	by	using	a	macro	MetaMorph	Raw	into	Stacks	(available	upon	request).	2.	Open	the	stacks	for	491	nm	and	561	nm	channels	for	the	first	oocyte.	3.	Select	a	square	region	of	interest	around	the	chromosome	mass	in	one	of	the	images	at	the	first	time	point	and	measure	the	fluorescence	intensity	within	this	region	with	the	ImageJ	function.		4.	Select	the	window	with	the	image	of	the	same	oocyte	taken	on	another	channel	and	restore	the	selected	region	of	 interest	 through	“Image	-	Selection	-	Restore	Selection”	 function	of	 ImageJ.	Measure	the	 fluorescence	 intensity	of	 this	region,	too	(Note	19).	
5.	Return	to	the	image	taken	with	the	first	channel,	switch	to	the	next	time	point,	adjust	the	region	of	interest	so	that	it	covers	the	moved	chromosome	mass	and	repeat	the	measurement	on	both	channels.	6.	Repeat	the	measurement	steps	until	the	chromosomes	segregate,	then	measure	only	the	chromosome	mass	that	stays	in	the	oocyte	until	the	end	of	the	time	lapse.	7.	 Measure	 the	 intensities	 of	 oocyte	 cytoplasm	 fluorescence	 in	 both	 channels	(background	fluorescence)	in	a	similar	manner.	8.	Subtract	background	fluorescence	from	the	chromosome	fluorescence	in	both	channels	respectively	for	each	time	point.	9.	Normalize	the	fluorescence	intensities	to	the	first	time	point	for	both	channels	individually.	On	a	line	chart	the	fluorescence	value	will	drop	in	both	channels	upon	chromosome	 segregation	 (Fig.	 2A,B	 left	 panels),	 indicative	 of	 chromosome	segregation.	10.	Calculate	the	ratio	between	YFP	and	RFP	fluorescence	intensities	for	each	time	point.	11.	Build	a	line	chart	of	the	ratio	changes	over	time.	Mark	the	time	point	when	the	chromosomes	 segregate,	 i.e.	 are	 first	 seen	 as	 2	 masses.	 The	 dip	 in	 the	YFP/mCherry	fluorescence	ratio	represents	the	time	of	Separase	activation	(Fig.	2B,	right	panel)	(see	Note	20).	12.	Repeat	steps	2-11	for	all	oocytes.		
Notes	
	1.	Any	plasmid	suitable	for	in	vitro	transcription	would	serve.	It	has	to	contain	a	transcription	start	(usually	T7,	T3	or	SP6	promoter),	a	Kozak	sequence,	the	sensor	cDNA	 (H2B,	 mCherry,	 Scc1	 107-268	 aa,	 YFP	 as	 a	 single	 reading	 frame)	 and	 a	polyadenylation	 signal	 sequence	 (can	 be	 replaced	 by	 a	 string	 of	 around	 30	adenosines	 in	 the	 coding	 strand).	 Include	 a	 unique	 restriction	 enzyme	 cut	 site	after	the	poly(A)	signal	for	plasmid	linearization.	2.	One	8-10	weeks	old	mouse	of	this	strain	usually	harbours	around	50	mature	GV	oocytes.	3.	The	collection	pipette	can	be	produced	from	a	glass	Pasteur	pipette.	Heat	up	a	thin	 section	of	 the	 pipette	 over	 a	 flame	until	 the	 glass	 becomes	malleable	 and	rapidly	pull	on	both	ends	of	the	pipette.	Break	off	the	extended	thin	portion	at	5-7	cm	and	check	the	diameter	of	the	opening.	The	diameter	of	the	pipette	opening	should	 not	 be	 smaller	 than	 the	 diameter	 of	 the	 oocyte.	 It’s	 better	 to	 prepare	pipettes	of	2	sizes,	one	around	2-3	diameters	of	the	oocyte	for	oocyte	collection,	and	 another	 with	 the	 diameter	 very	 close	 to	 the	 diameter	 of	 the	 oocyte	 for	cleaning.	4.	To	determine	the	puller	settings,	 follow	the	manufacturer’s	 instructions.	The	settings	and	the	resulting	needle	will	have	to	be	adjusted	for	individual	conditions	in	the	lab.	5.	Use	a	P-10	automatic	pipette	with	Eppendorf	Microloader	tips	to	reach	inside	the	microinjection	 needle	 from	 the	wide	 end.	 In	 case	 air	 bubbles	 appear	 after	loading	the	needle	with	mRNA	solution,	tap	lightly	on	the	side	of	the	needle.	mRNA	can	 also	 be	 loaded	with	 a	 regular	 10	 μl	 tip	 by	 placing	 the	 drop	 of	 the	 mRNA	solution	on	top	of	 the	wider	end	of	 the	microinjection	needle.	The	solution	will	travel	to	the	working	end	of	the	needle	by	capillary	forces	within	5-10	minutes.	
6.	After	the	tip	of	the	holding	pipette	is	lowered	into	the	medium,	use	the	holding	pipette	pump	to	take	in	some	medium	in	the	holding	pipette	and	equilibrate	the	suction	so	that	it	doesn’t	take	any	medium	in	or	out.	Also,	sometimes	the	tip	of	the	microinjection	needle	can	be	sealed	during	pulling.	Test	this	by	pressing	“Clean”	button	on	the	microinjector	for	a	second.	If	the	tip	of	the	needle	is	not	sealed,	an	air	bubble	should	exit.	If	the	tip	is	sealed,	it	can	be	broken	off	by	tapping	the	tip	of	the	needle	against	the	holding	pipette.	7.	The	force	of	the	flow	required	for	a	successful	injection	depends	on	the	diameter	of	the	needle.	At	the	beginning	of	the	injections	set	the	force	to	150	hPa	and	adjust	accordingly	to	the	injection	outcome.	8.	 In	 absence	 of	 an	 anti-vibration	 table,	 if	 the	 holding	 pipette	 tremors	 slightly	adjust	it	so	it	touches	lightly	the	glass	slide	The	microscope	should	be	 focused	on	the	middle	of	 the	opening	of	 the	holding	pipette,	 which	 is	 also	 the	 centre	 of	 the	 oocyte	 attached	 to	 the	 pipette.	 The	microinjection	needle	should	be	adjusted	so	that	only	the	very	end	of	the	needle	is	in	focus.	9.	Sometimes	the	tip	of	the	needle	is	not	well	positioned	against	the	centre	of	the	oocyte	and	upon	injection,	it	can	slide	between	the	zona	pellucida	and	the	oocyte	membrane.	 If	 this	 happens,	 a	 bubble	 appears,	 created	 by	 the	 constant	 flow	 of	mRNA	from	the	needle.	Withdraw	the	needle,	readjust	its	position	and	try	again.	10.	It	is	very	easy	to	rupture	the	membrane	of	the	oocyte.	Always	withdraw	the	needle	at	the	same	angle	as	the	injection	path.	Do	not	inject	too	much:	the	area	of	the	 cytoplasmic	 burst	 upon	 injection	 should	 not	 exceed	 the	 diameter	 of	 the	nucleus.	Make	 sure	 the	 tip	 of	 the	 injection	 needle	 is	 thin	 enough	 and	 is	 clean.	Sometimes	the	material	from	the	cytoplasm	can	stick	to	the	tip	of	the	needle.	This	greatly	increases	the	probability	of	the	membrane	rupture	of	the	oocytes	injected	after	that.	Clean	the	needle	by	rubbing	its	sides	against	the	sides	of	the	holding	pipette.	Exchange	the	needle	if	needed.	Sometimes	mRNA	solution	can	contain	a	small	amount	of	precipitates,	which	can	clog	the	injection	needle.	It	is	visible	in	the	injection	microscope	as	a	mass	inside	the	 needle.	 Sometimes	 it	 can	 be	 cleared	 by	 applying	 extra	 pressure	 from	 the	microinjector	(press	“Clean”	several	times).	If	possible	(depending	on	the	length	of	the	injection	needle	and	its	diameter),	try	to	break	off	the	end	of	the	injection	pipette	by	bumping	it	softly	onto	the	holding	pipette.	If	the	clog	does	not	exit	the	needle,	exchange	the	needle.	The	 concentration	of	 the	mRNA	 solution	 can	also	 influence	 the	 clogging.	 If	 the	injection	is	very	difficult,	try	diluting	the	mRNA	solution	with	RNAse-free	water	and	repeat	the	microcentrifugation	step.	11.	 Dead	 oocytes	 have	 a	 more	 granulated	 cytoplasm	 and	 are	 slightly	 less	transparent	than	intact	oocytes.	If	the	membrane	is	ruptured,	a	slow	movement	of	cytoplasm	can	be	visible.	Sometimes	the	membrane	remains	intact	but	the	oocytes	die	anyway.	Don't	be	disappointed	if	most	oocytes	die	in	the	beginning!.	12.	The	incubation	time	depends	on	the	expression	of	the	target	protein.	Longer	incubation	tends	to	increase	the	expression	levels.	13.	 	The	time	of	meiosis	resumption	after	release	from	dbcAMP	depends	on	the	mouse	strain,	source	of	 the	medium	and	the	time	of	 incubation	 in	the	arrested	state	 (in	 dbcAMP-supplemented	 M2).	 Variations	 between	 45	 and	 80	 min	 are	normal.	To	keep	the	oocyte	culture	synchronised	do	not	collect	any	oocytes	that	went	through	GVBD	after	15-20	minutes	after	the	first	batch.	
14.	Due	to	oocyte	sensitivity	to	phototoxicity,	it	is	best	not	to	expose	oocytes	to	the	laser	light	before	GVBD+4h	in	this	assay.	15.	Setting	up	the	right	temperature	conditions	is	the	key	to	successful	imaging.	Oocyte	culture	 is	very	sensitive	to	 temperature	changes	and	even	1°C	variation	interferes	with	meiotic	progression.	The	best	way	to	adjust	the	temperature	is	by	experimental	testing.	The	temperature	inside	of	the	drop	in	the	imaging	chamber	should	be	around	38°C.	This	can	be	measured	initially	using	a	thermometer	with	a	wire	temperature	probe.	Then	try	incubating	the	oocytes	overnight	in	the	heated	microscope	 in	 the	 imaging	 chamber.	 If	 the	 conditions	 are	 optimal,	 the	 oocytes	should	be	alive	and	have	extruded	polar	bodies	(PB)	at	GVBD+7h.	If	the	oocytes	are	still	in	metaphase	I,	but	visually	unaffected,	the	temperature	is	probably	too	low.	If	the	oocytes	are	in	metaphase	I,	but	look	unhealthy,	i.e.	with	very	granulated	cytoplasm,	uneven	surface,	full	of	bubbles,	or	even	dead,	the	temperature	may	be	too	 high.	 Another	 reason	 for	 failures	 in	 meiotic	 progression	 can	 be	 the	composition	of	the	imaging	chamber	(certain	materials	are	toxic	for	the	oocytes)	or	the	source	of	the	medium	and	mineral	oil.		To	keep	the	microscope	temperature	stable,	we	keep	the	heating	chamber	around	the	microscope	at	a	constant	temperature	at	all	times.	16.	We	place	15	oocytes	per	drop,	 evenly	 spaced.	Time-lapse	 imaging	with	 the	current	 set	 up	 (described	 later)	 is	 optimal	 for	 up	 to	 30	 oocytes.	 If	 there	 is	 no	difference	 in	oocyte	 treatment	 conditions,	2	drops	of	medium	 is	 enough.	 If	 the	conditions	are	different	(i.e.	drug	treatments,	injection	of	different	constructs),	use	separate	drops	of	medium	to	place	oocytes	from	different	conditions.	In	case	of	drug	treatments,	it	is	essential	to	make	sure	that	the	drug	is	not	lipophilic	as	it	may	affect	 the	 untreated	 oocytes	 through	diffusion	 in	 the	mineral	oil.	 If	 the	 drug	 is	lipophilic,	also	add	it	to	the	oil	in	the	matching	final	concentration	so	there	is	an	equilibrium	maintaining	the	correct	concentration	in	the	medium.	17.	Ooocytes	are	very	sensitive	to	phototoxicity.	Try	using	a	very	low	laser	power	and	exposition	times,	where	chromosomes	are	still	visible.	If	there	are	still	effects	of	 phototoxicity	 (chromosome	missegregations,	 lagging	 chromosomes),	 reduce	the	number	of	the	oocytes	per	time-lapse	experiment.	18.	As	acquisitions	take	place	for	8-10	hours,	it’s	advisable	to	schedule	the	time	lapse	imaging	overnight.		19.	It	is	important	that	the	region	of	interest	has	the	exact	same	location	in	images	from	both	channels	at	the	same	time	point.	To	simplify	the	measuring	routine	you	can	use	the	Sensor	Measurement	Plugin	(available	upon	request).	20.	The	rapid	decrease	of	the	YFP/mCherry	ratio	upon	chromosome	segregation	represents	the	cleavage	of	the	sensor	by	Separase	(Fig.	2B).	Note	that	despite	the	drop	in	both	mCherry	and	YFP	fluorescence	intensity	in	the	negative	control	H2B-mCherry-YFP	 (Fig.	 2A,	 left	 panel),	 the	 YFP/mCherry	 ratio	 remains	 unchanged	during	the	chromosome	segregation	event	(Fig.	2A,	right	panel).		As	Scc1	is	a	very	good	Separase	substrate,	it	is	cleaved	almost	completely	(Fig.	2B).	Often	the	area	of	the	chromosomes	after	sensor	cleavage	has	lower	fluorescence	intensity	than	the	rest	of	the	cytoplasm;	this	is	why	the	curve	dips	below	zero.	After	the	cleavage	and	a	rapid	decrease	in	YFP/mCherry	ratio,	it	slowly	grows	back	up.	We	believe	this	behaviour	represents	replacement	of	the	cleaved	sensor	molecules	with	the	intact	ones	still	 found	 in	the	cytoplasm	(or	newly	synthesized	molecules	of	 the	sensor).	We	believe	that	the	time	between	the	start	of	sensor	cleavage	(the	dip	of	the	 ratio	 curve)	 and	 the	 reaccumulation	 of	 uncleaved	 sensor	 (end	 of	 the	 dip)	
represents	the	time	window	of	Separase	activity.	The	efficiency	of	the	cleavage	can	be	estimated	by	the	speed	of	the	cleavage	and	whether	or	not	most	of	the	sensor	molecules	were	cleaved	during	the	time	where	Separase	was	active.			
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Figure	legends		
Figure	1.	Live	imaging	of	Separase	activity	in	mouse	oocyte		At	5h30	mark	(metaphase	I),	the	intact	cleavage	sensor	(H2b-mCherry-Scc1-YFP)	is	observed	at	the	chromosomes.	Once	Separase	is	activated	at	anaphase	I	onset	(8h30	mark),	it	cleaves	Scc1.	This	leads	to	a	sharp	decrease	of	YFP,	leaving	only	the	signal	mCherry	on	the	chromosomes.		
	
Figure	2.	Quantification	of	YFP	and	mCherry	fluorescence	
A)	Quantification	of	YFP	and	mCherry	fluorescence	of	the	negative	control	(H2B-mCherry-YFP)	measured	on	the	chromosomes	by	live	imaging	of	a	mouse	oocyte	during	 metaphase	 to	 anaphase	 I	 transition	 (left)	 and	 the	 ratio	 of	 normalized	YFP/mCherry	 fluorescence	 intensity	 by	 live	 imaging	 of	 a	mouse	 oocyte	 during	metaphase	to	anaphase	I	 transition.	Black	circle:	chromosome	segregation	time	point.	B)	Quantification	of	YFP	and	mCherry	fluorescence	of	the	cleavage	sensor	(H2B-mCherry-Scc1(107-268aa)-YFP),	 measured	 on	 the	 chromosomes	 by	 live	imaging	of	a	mouse	oocyte	during	metaphase	to	anaphase	I	transition	(left)	and	the	ratio	of	normalized	YFP/mCherry	fluorescence	intensity	by	live	imaging	of	a	mouse	 oocyte	 during	 metaphase	 to	 anaphase	 I	 transition.	 Black	 circle:	chromosome	segregation	time	point.		
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